InspireMD Announces Issuance of Key U.S. Patent Covering Its SwitchGuard™ Neuroprotection System - InspireMD (NASDAQ:NSPR)

TEL AVIV, Israel and MIAMI, Dec. 20, 2023 (GLOBE NEWSWIRE) -- InspireMD (NASDAQ:NSPR), developer of the CGuard™ Embolic Prevention Stent System (EPS) for the prevention of stroke, announced today the issuance of

Related Keywords

Israel ,United States ,Miami ,Florida ,Marvin Slosman ,Chuck Padala ,Exchange Commission ,Nasdaq ,Inspiremd Inc ,Centers For Medicare ,Medicaid Services ,Company Annual Report On Form ,Embolic Prevention Stent System ,Blood Flow Indicators ,Neuroprotection System ,Transcarotid Artery Revascularization ,Chief Executive Officer ,Prime Carotid Stent System ,Investigational Device Exemption ,Annual Report ,Quarterly Reports ,